Effect of Chronic Kidney Disease or Anemia or Both on Cardiovascular Mortality in a 25-Year Follow-Up Study of Japanese General Population (From NIPPON DATA90)
Introduction
Chronic kidney disease (CKD), a cause of end-stage renal disease, has been a global public health problem in the aging society.1 In a large community-based population, CKD increases the risks of mortality, cardiovascular events, and hospitalization.2 Numerous patient-based studies3, 4, 5, 6, 7, 8, 9, 10, 11 described that anemia in patients with kidney disease worsens the prognosis. However, the effect of CKD and anemia on cardiovascular disease (CVD) in general populations is still insufficiently examined. Anderson et al12 investigated CKD with anemia and showed reduced survival in patients with established CVD. The management of CKD and anemia is an important public health concern. However, to our knowledge, only a few studies have investigated the association between CKD and CVD mortality with and without anemia in community-dwelling general populations. Hence, we aimed to conduct a 25-year follow-up study on such association in a representative sample of the Japanese general population.
Section snippets
Methods
NIPPON DATA is a collection of cohort studies that followed up individuals as a representative sample of the Japanese population from 1990 to 2015 in accordance with the National Survey on Cardiovascular Diseases in Japan. Specifically, NIPPON DATA includes 3 long-term cohort studies, with baseline surveys conducted in 1980, 1990, and 2010, which are called as NIPPON DATA80, NIPPON DATA90, and NIPPON DATA 2010, respectively. The details of these cohorts were reported previously.13, 14, 15, 16
In
Results
The mean values and prevalence of the baseline characteristics of the patients are summarized by the combination of CKD and anemia information (Tables 1 and 2).
Table 3 shows the distribution of eGFR by gender in this population. Table 4 shows the distribution of anemia by gender in this population. The percentage below mild anemia was approximately 7% in menand 19% in women. Anemia was more prevalent among women.
Table 5 lists the adjusted HRs and 95% CIs for CVD mortality in men and women
Discussion
This study investigated the effects of CKD and anemia on CVD in a general population. In this study, the cut-off value for anemia was based on clinical mild anemia. Results showed that the combination of CKD and anemia is an independent risk factor for CVD in both genders. Although CKD alone is a risk factor for CVD in both men and women, even mild anemia per se is a risk factor for CVD in men. The risk of combined CKD and anemia was higher than that of CKD or anemia alone.
A large, globally
Disclosures
The authors have no conflicts of interest to declare.
Acknowledgment
The authors would like to express their deepest gratitude to Professor O.T. for his great guidance throughout this research as my supervisor. The authors would also like to thank NIPPON DATA research team for their appropriate advice as secondary reviewers in the preparation of this thesis.
References (30)
- et al.
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
Kidney Int
(2011) - et al.
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients
Atherosclerosis
(2010) - et al.
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Am J Kidney Dis
(1996) - et al.
A combination of serum low albumin and above-average cholesterol level was associated with excess mortality
J Clin Epidemiol
(2004) - et al.
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate
Am J Kidney Dis
(2002) - et al.
Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan
Am J Kidney Dis
(2009) - et al.
Relations of anemia With the all-cause mortality and cardiovascular mortality in general population: a meta-analysis
Am J Med Sci
(2019) - et al.
Anemia, renal dysfunction, and their interaction in patients with chronic heart failure
Am J Cardiol
(2006) - et al.
Anemia and the heart in chronic kidney disease
Semin Nephrol
(2006) - et al.
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
N Engl J Med
(2004)
Impact of anemia and chronic kidney disease on the risk of cardiovascular disease and all-cause mortality among diabetic patients
Beijing Da Xue Xue Bao Yi Xue Ban
Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: the CKD-ROUTE study
Nephrology (Carlton)
Anaemia is common and predicts mortality in diabetic nephropathy
QJM
Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes
Diabetes Care
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
BMC Nephrol
Cited by (0)
Funding: This study was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare (Tokyo, Japan) under the auspices of the Japanese Association for Cerebro-Cardiovascular Disease Control (Tokyo, Japan ), a Research Grant for Cardiovascular Diseases (7A-2) from the Ministry of Health, Labour and Welfare, and Health and Labour Sciences Research Grants, Japan (Comprehensive Research on Aging and Health H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014 and Comprehensive Research on Life-Style Related Diseases including cardiovascular Diseases and Diabetes Mellitus H22-Junkankitou-Seishuu -Sitei-017, H25-Junkankitou-Seishuu-Sitei-022, H30-Junkankitou-Sitei-002, 21FA2002).